Таксономия возбудителей и применение Максаквина и ципрофлоксации а в лечении осложненных инфекций мочевыводящих путей

1. Andriole V. Use of quinolones in treatm ent of prostatitis and lower urinary tract infections / / Eur.J.Clin.Microbiol.Infect.Dis.— 1991.— Vol. 10.— P. 342— 350.

2. Cox C.E. A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin for treatm ent of serious urinary tract infections / / Am .J.Med.— 1992.— Vol. 92, № 6 .— Suppl.4A .— P. 82 S— 86 S.

3. Fass R .J. Efficacy and safety of oral ciprofloxacin for treatm ent of serious urinary tract infections / / Antimicrob. Agents Chcm other.— 1987.— Vol. 3 1 .— P. 148— 150.

4. Mcint T.G.K. Multiple-dose pharm acokinetics of lomefloxacin: rationale for once-a-day dosing / / Am .J.M ed.— 1992.— Vol. 92, № 6 .— Suppl.4 A .— P. 26 S— 32 S.

5. Naber K .G., Baurnfeind A ., Diellein G., Wittenberger R . Urinary tract infections in elderly urological patients / / New Trendsin Urinarv Tract Infections / Ed. H.C .Neu , J.D .Williams.— Basel: Kargcr, 1988.— P. 48— 61.

6. . Nea H .C. Quinolones: a new class of antimicrobial with wide potential uses / / Med.Clin.North Am.— 1988.— Vol. 7 2 .— P. 623— 626.

7. Neu H.C . Urinary tract infections / / Am .J.Med.— 1992.— Vol. 92, № 6 .— Suppl.4A .— P. 63 S— 70 S.

8. . Siporin C. The evalution of the fluorinated quinolons: pharm acology, microbiological activity, clinical uses, toxicises / / Ann.Rev.Microbiol.— 1989.— Vol. 4 3 .— P. 601— 627.

9. Wise R ., Andrews J .M ., Ash ly J .P ., Motthews R .S . In vitro activity of lom efloxacin, a new quinolone antimicrobial agentin comparison to those of other agents / / Antimicrob.Agents Chemother.— 1988.— Vol. 3 2 .— P. 617— 622.

10. Wordwordth A .N ., Goa K.L. Lomefloxacin: a review of its antim icrobial activity, pharm acokinetic properties and therapeutic use / / Drugs.— 1991.— Vol. 42, № 6 .— P. 1018— 1060.